Aaron Brinkworth
Non-Executive Director / Resonance Health
Aaron Brinkworth had a 22-year career with US headquartered and Nasdaq-listed Gilead Sciences Inc where he held several commercial, licensing, and patient access roles. As executive director of Gilead Sciences Global Patient Solutions, he was responsible for developing and implementing comprehensive commercial & access strategies for emerging markets. He led its commercial and access operations in the Asia Pacific and was responsible for its branded product business, managing a geographically dispersed team and partners across 31 Asia Pacific countries including China, India, and Vietnam.
Mr Brinkworth has a Bachelors degree in Health Sciences from Edith Cowan University, and is a graduate of the Australian Institute of Company Directors.
